Announcements Trials
Browse Landscape

Phase

Phase 2 34Phase 1 21Phase 1/2 7Phase 3 5Phase NA 1Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Neoplasms 3Recurrence 1Pancreatic Neoplasms 1Oligometastatic Lung Adenocarcinoma 1Neoplasm Metastasis 1NSCLC 1Lung Neoplasms 1Head and Neck Neoplasms 1Glioma 1Gastrointestinal Neoplasms 1EGFR Mutation Positive Non-small Cell Lung Cancer 1Carcinoma 1Breast Neoplasms 1

Interventions

Standard of Care 18Gemcitabine 18Radiosurgery 14Drug Therapy 13Blood Specimen Collection 13Endoscopic Ultrasound-Guided Fine Needle Aspiration 11Exercise 10Pancreaticoduodenectomy 9Practice Guidelines as Topic 8Methods 8Magnetic Resonance Spectroscopy 8Biopsy, Fine-Needle 8Capecitabine 7Early Intervention, Educational 6Biopsy 6Surveys and Questionnaires 5Stents 5Specimen Handling 5Resistance Training 5Radiofrequency Ablation 5Psychiatric Rehabilitation 5Oxaliplatin 5Fluorouracil 5Cholangiopancreatography, Endoscopic Retrograde 5130-nm albumin-bound paclitaxel 5Secretin 4Radiotherapy 4Irinotecan 4Heavy Ion Radiotherapy 4Electroporation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Pancreatic Neoplasms × Erlotinib Hydrochloride × Clear all
NCT01683422 2021-08-10

Chemotherapy Plus Proton-chemotherapy for Locally Advanced Pancreatic Cancer

Loma Linda University

Phase NA Terminated
9 enrolled 8 charts
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡